CONMED PE Ratio 2010-2022 | CNMD

Current and historical p/e ratio for CONMED (CNMD) from 2010 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. CONMED PE ratio as of September 26, 2022 is 24.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

CONMED PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2022-09-27 77.78 0.00
2022-06-30 95.56 $-3.96 0.00
2022-03-31 147.92 $2.10 70.44
2021-12-31 140.95 $1.94 72.65
2021-09-30 129.89 $2.00 64.94
2021-06-30 136.22 $1.76 77.40
2021-03-31 129.25 $0.39 331.42
2020-12-31 110.68 $0.28 395.27
2020-09-30 77.59 $-0.04 0.00
2020-06-30 70.84 $-0.04 0.00
2020-03-31 56.20 $1.11 50.63
2019-12-31 109.43 $0.95 115.19
2019-09-30 93.91 $1.00 93.91
2019-06-30 83.41 $0.97 85.99
2019-03-31 80.89 $1.08 74.90
2018-12-31 62.27 $1.41 44.17
2018-09-30 76.62 $2.52 30.40
2018-06-30 70.62 $2.58 27.37
2018-03-31 60.93 $2.12 28.74
2017-12-31 48.89 $1.99 24.57
2017-09-30 50.12 $0.60 83.54
2017-03-31 42.10 $0.44 95.68
2016-12-31 41.67 $0.52 80.14
2016-09-30 37.63 $0.56 67.19
2016-06-30 44.60 $0.62 71.94
2016-03-31 39.01 $0.79 49.38
2015-12-31 40.78 $1.10 37.07
2015-09-30 43.98 $1.23 35.76
2015-06-30 53.47 $0.98 54.57
2015-03-31 46.17 $1.08 42.75
2014-12-31 40.95 $1.07 38.27
2014-09-30 33.41 $1.02 32.75
2014-06-30 39.83 $1.15 34.64
2017-06-30 48.48 $1.12 43.28
2013-12-31 38.00 $1.27 29.92
2013-09-30 30.21 $1.29 23.42
2013-06-30 27.67 $1.40 19.76
2013-03-31 30.03 $1.38 21.76
2012-12-31 24.52 $1.37 17.90
2014-03-31 39.03 $1.34 29.12
2012-09-30 24.87 $0.13 191.31
2012-06-30 24.02 $0.10 240.15
2012-03-31 25.78 $0.04 644.48
2011-12-31 22.04 $-0.00 0.00
2011-09-30 19.76 $1.14 17.33
2011-06-30 24.45 $1.16 21.08
2011-03-31 22.57 $1.11 20.33
2010-12-31 22.69 $1.05 21.61
2010-09-30 19.24 $0.98 19.64
2010-06-30 16.00 $0.71 22.53
2010-03-31 20.44 $0.51 40.09
2009-12-31 19.58 $0.41 47.75
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.435B $1.011B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $66.063B 19.19
McKesson (MCK) United States $49.282B 14.31
AmerisourceBergen (ABC) United States $28.260B 12.61
Laboratory Of America Holdings (LH) United States $19.507B 8.53
West Pharmaceutical Services (WST) United States $18.722B 28.50
Cardinal Health (CAH) United States $17.923B 13.00
Cooper (COO) United States $13.274B 20.77
Invacare (IVC) United States $0.031B 0.00